NADK and myalgic encephalomeyelitis/chronic fatigue syndrome: NAD is phosphorylated by NAD kinase to form NADP (295). From there, it is reduced to NADPH by NADP dehydrogenase. NADPH acts as an antioxidant to neutralise high levels of ROS (296). Interestingly, this beneficial mechanism is increased in ME/CFS.